tiprankstipranks
SomnoMed Exceeds Revenue Forecasts, Restructures
Company Announcements

SomnoMed Exceeds Revenue Forecasts, Restructures

Somnomed Limited (AU:SOM) has released an update.

Don't Miss our Black Friday Offers:

SomnoMed Limited has reported a successful fiscal year, with an unaudited FY24 revenue of $91.7 million, marking a 9.6% increase from the previous year and surpassing revised forecasts. The company has completed its planned cost reductions, leading to restructuring costs of $3 million, but anticipates annualized savings of $5 million from Q1 FY25. Additionally, key appointments were made with Mr Jonathan Vowels and Ms Mary Kennell taking on senior roles, and the company fully repaid its debt facility, projecting interest cost savings of $1.7 million in FY25.

For further insights into AU:SOM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskSomnoMed Limited Shows Strong Cash Flow Momentum
TipRanks Australian Auto-Generated NewsdeskSomnoMed Limited Sees Strong Growth and FDA Milestone
TipRanks Australian Auto-Generated NewsdeskSomnoMed Limited Invites Shareholder Participation in Key Votes
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App